BOTOX® Cosmetic and Injectable Dermal Fillers
VitaFlow offers a number of non-surgical BOTOX and dermal fillers treatments at our Gainesville location. These treatments can reduce signs of aging in the face for a more youthful and refreshed appearance. With BOTOX® Cosmetic and a number of dermal filler options, we can reduce the appearance of wrinkles and fine lines, as well as add volume to the lips. Many of our cosmetic BOTOX and dermal fillers procedures can be performed in about 30 minutes or less, and there is typically no downtime necessary after treatment.
BOTOX treatment is one of the most popular aesthetic enhancement treatments available. This innovative procedure is designed to diminish facial creases, frown lines, crow’s feet, and other signs of age. BOTOX® Cosmetic is derived from a purified form of botulinum toxin type A. The solution works to prevent muscles from contracting in the areas targeted for treatment. This muscle contraction is what often causes wrinkles to appear. Injections are made with a very fine needle in the target areas, and a numbing agent can be applied to minimize discomfort during the procedure. Patients should be able to resume normal daily activities immediately. While there may be some redness and swelling around the injection sites after treatment, this should dissipate within a few hours. Results from BOTOX treatment often last for four months, and can be maintained with follow-up treatments.
Why Have Botox Treatments?
If you feel that forehead creases and lines, frown lines between your brows, or crow’s feet add years to your look, consider BOTOX injections. Take note that the skills of your injector are the most critical aspect of a achieving a fresh, natural result. The last thing you want is to have your face appear expressionless, uneven, or frozen.
Should I Try Botox?
If you are troubled by any of the following facial issues, you are likely a good candidate for BOTOX injections:
Vertical lines between brows
Will I Continue To Need Botox?
Not necessarily. In many cases, continued treatments “train” the injected muscles so that they remain more relaxed and continue to do so over time. Many patients have remarked that they require less units to maintain a fresh, rejuvenated look. Others may notice the product is no longer working as it once did and may be advised to try injections with another neuromodulator, Dysport.
What Are The Risks of Botox?
BOTOX has been administered to hundreds of thousands of pf people annually and is very safe. Further, it only stays in the body for a period of approximately six months, so unwanted side effects are temporary. However, as small bruise, of a drooping eyelid, or the inability to control facial muscles that were not intended for treatment, or a “frozen look” from being over-injected can be both uncomfortable as well as unsightly.
How Long Before I See Results?
With BOTOX, you will need to be patient as the formula does its work. The fading of facial wrinkles and lines requires several days to appear, typically with full effect in about one week. The smoothing effect lasts for many months, but slowly, as your body sheds the product, the lines and wrinkles will once again appear. Most patients require retreatment about every three months, with some variation, person to person.
ABOUT BOTOX® COSMETIC?
Choose the brand medical providers and patients know and trust: BOTOX® Cosmetic. It's the #1 selling treatment of its kind*:
The first and only treatment FDA-approved to temporarily make moderate to severe frown lines, crow's feet and forehead lines look better in adults
Treatment requires minimal downtime. You can return to your daily routine immediately after you leave your specialist's office
You may begin to notice results within 24 to 48 hours for moderate to severe frown lines. Full results in 30 days
It delivers predictable, subtle results, so you look like you, only with less noticeable facial lines
BOTOX® COSMETIC (ONABOTULINUMTOXINA) IMPORTANT INFORMATION
IndicationsBOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:
Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
Moderate to severe lateral canthal lines associated with orbicularis oculi activity
Moderate to severe forehead lines associated with frontalis activity
WARNING: DISTANT SPREAD OF TOXIN EFFECT
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses, including spasticity in children, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.
BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.
Warnings and Precautions
Lack of Interchangeability between Botulinum Toxin Products
The potency Units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.
Spread of Toxin Effect
Please refer to Boxed Warning for Distant Spread of Toxin Effect.
No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported.
Serious Adverse Reactions With Unapproved Use
Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.
Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.
There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.
Increased Risk of Clinically Significant Effects with Pre-existing Neuromuscular Disorders
Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).
Dysphagia and Breathing Difficulties
Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).
Pre-existing Conditions at the Injection Site
Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).
Human Albumin and Transmission of Viral Diseases
This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.
The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for glabellar lines was eyelid ptosis (3%).
The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%) and eyelid ptosis (2%).
Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.
The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.
Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.
Use In Specific Populations
There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.
Please see BOTOX® Cosmetic full Prescribing Information including Boxed Warning and Medication Guide.
INJECTABLE DERMAL FILLERS
INJECTABLE DERMAL FILLERS
Did you know that many visible signs of aging can be traced back to volume loss? As facial tissues thin out, lines become etched around the nose and mouth and cheeks look a little hollow. Dermal fillers can replace lost volume to help smooth wrinkles, plump the lips, and restore a more youthful appearance. Injectable dermal fillers can help you reduce signs of aging and add volume and new definition to facial features. With popular options such as JUVÉDERM®, and Restylane®, VitaFlow can fill in deep wrinkles, smooth out lines and creases between the nose and mouth (nasolabial folds), and renew contours in the lips, and other areas. Many of our dermal filler options are composed of hyaluronic acid, a substance that occurs naturally in the human body, and do not require an allergy test. Treatments involve injection of the dermal filler into the areas targeted for rejuvenation. A local anesthetic can be applied to these areas so you are as comfortable as possible during the procedure. Most treatments last only about 30 minutes, and patients can typically resume their daily routines immediately. Results from dermal fillers will vary depending on which type of filler you receive; however, many of the dermal fillers we use have very long-lasting effects – six months to a year in some cases. Plus, you can keep the effects going with occasional “touch-up” treatments.